Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials

BACKGROUND/AIMS: To evaluate the efficacy of antivascular endothelial growth factor (anti-VEGF) agents pretreatment before vitrectomy for patients with complicated proliferative diabetic retinopathy (PDR). METHODS: The PubMed, Embase and the Cochrane Central Register of Controlled Trials were search...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xin-yu, Xia, Song, Chen, You-xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059039/
https://www.ncbi.nlm.nih.gov/pubmed/29246890
http://dx.doi.org/10.1136/bjophthalmol-2017-311344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059039/
https://www.ncbi.nlm.nih.gov/pubmed/29246890
http://dx.doi.org/10.1136/bjophthalmol-2017-311344

Ejemplares similares